Fennec Pharmaceuticals (FENC) Operating Income (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,270.90% |
| Sep 30, 2025 | 93.08% |
| Jun 30, 2025 | -238.12% |
| Mar 31, 2025 | 13.49% |
| Dec 31, 2024 | 82.05% |
| Sep 30, 2024 | -3.23% |
| Jun 30, 2024 | -136.67% |
| Mar 31, 2024 | 855.94% |
| Dec 31, 2023 | -78.76% |
| Sep 30, 2023 | 78.20% |
| Jun 30, 2023 | 11.46% |
| Mar 31, 2023 | 14.10% |
| Dec 31, 2022 | 22.33% |
| Sep 30, 2022 | -57.70% |
| Jun 30, 2022 | -41.26% |
| Mar 31, 2022 | 15.71% |
| Dec 31, 2021 | -0.81% |
| Sep 30, 2021 | -6.45% |
| Jun 30, 2021 | 20.37% |
| Mar 31, 2021 | -47.13% |
| Dec 31, 2020 | 42.89% |
| Sep 30, 2020 | -20.93% |
| Jun 30, 2020 | -26.34% |
| Mar 31, 2020 | -4.98% |
| Dec 31, 2019 | -96.08% |
| Sep 30, 2019 | 61.29% |
| Jun 30, 2019 | -79.59% |
| Mar 31, 2019 | 13.69% |
| Dec 31, 2018 | -9.02% |
| Sep 30, 2018 | -6.87% |
| Jun 30, 2018 | -48.80% |
| Mar 31, 2018 | 28.79% |
| Dec 31, 2017 | -15.05% |
| Sep 30, 2017 | -47.80% |
| Jun 30, 2017 | -91.83% |
| Mar 31, 2017 | 32.72% |
| Dec 31, 2016 | -103.19% |
| Sep 30, 2016 | 20.23% |
| Jun 30, 2016 | -55.73% |
| Mar 31, 2016 | 17.60% |
| Dec 31, 2015 | -63.02% |
| Sep 30, 2015 | 38.43% |
| Jun 30, 2015 | -21.46% |
| Mar 31, 2015 | 42.86% |
| Dec 31, 2014 | -27.79% |
| Sep 30, 2014 | 33.44% |
| Jun 30, 2014 | -73.18% |
| Mar 31, 2014 | -29.09% |
| Dec 31, 2013 | -715.69% |
| Sep 30, 2013 | 94.50% |
| Jun 30, 2013 | -72.63% |
| Mar 31, 2013 | 52.18% |
| Dec 31, 2012 | -78.25% |
| Sep 30, 2012 | 49.60% |
| Jun 30, 2012 | -102.92% |
| Mar 31, 2012 | 31.71% |
| Dec 31, 2011 | 4.45% |
| Sep 30, 2011 | -65.03% |
| Jun 30, 2011 | 43.98% |
| Mar 31, 2011 | -25.12% |
| Dec 31, 2010 | 11.01% |
| Sep 30, 2010 | 63.39% |